Intravenous Etomidate for Procedural Sedation in Emergency Department Patients
Open Access
- 1 January 2001
- journal article
- Published by Wiley in Academic Emergency Medicine
- Vol. 8 (1) , 13-18
- https://doi.org/10.1111/j.1553-2712.2001.tb00539.x
Abstract
Objective: To determine the safety and effectiveness of intravenous (IV) etomidate for the sedation of patients undergoing painful procedures in the emergency department (ED). Methods: A two‐part feasibility study for ED patients receiving IV etomidate for painful ED procedures was undertaken. In the initial phase, a retrospective series of patients receiving etomidate for ED procedural sedation was considered. This phase served as the basis for a descriptive, prospective feasibility study of consecutive ED patients. During the second phase, patients were evaluated for complications related to IV etomidate sedation or the procedure performed. Immediately following the procedure, the physician was asked to complete a data collection sheet documenting the patient's etomidate dose, the number of doses required to complete the procedure, the analgesic used, the complications of the procedure, and the patient's procedural recall. Results: Intravenous etomidate was administered to nine patients during the initial study phase and 51 during the prospective, descriptive phase. Indications for sedation included dislocation reduction (25), cardioversion (7), fracture reduction (20), abscess incision and drainage (4), foreign body removal (3), and chest thoracostomy (1). Physicians used 0.1‐mg/kg IV bolus etomidate. A mean of 1.6 doses of etomidate was used to complete procedures (range 1‐3 doses). Of the 60 patients in both study groups, 59 (98%) achieved adequate sedation by physician's assessment. Procedural success was documented for 56 patients (93%). There were 12 complications reported: oxygen desaturation below 90% (5), myoclonus (4), vomiting (1), pain with injection (1), and a brief bradycardic episode (1). No patient required assistance with ventilation or endotracheal intubation. Conclusions: Intravenous etomidate can be administered safely and effectively to provide appropriate conscious sedation for short, painful ED procedures.Keywords
This publication has 12 references indexed in Scilit:
- Reducing Myoclonus after EtomidateAnesthesiology, 1999
- Oral Transmucosal Etomidate in VolunteersAnesthesiology, 1998
- Conscious Sedation With Combined Hypnotic Agents for Implantation of Implantable Cardioverter-DefibrillatorsJournal of the American College of Cardiology, 1997
- A review of etomidate for rapid sequence intubation in the emergency departmentThe Journal of Emergency Medicine, 1997
- Etomidat versus Propofol zur Anästhesie bei ambulanter KardioversionAINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie, 1996
- Discharge criteria — a new trendCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 1995
- Are discharge criteria changing?Journal of Clinical Anesthesia, 1993
- Effects of thiopentone, etomidate and propofol on the haemodynamic response to tracheal intubationAnaesthesia, 1988
- Etomidate: A New Intravenous Anesthetic Induction AgentPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1983
- EFFECT OF ETOMIDATE ON INTRACRANIAL PRESSURE AND CEREBRAL PERFUSION PRESSUREBritish Journal of Anaesthesia, 1979